Article
MicroRNA as Biomarkers for Platelet Function and Maturity in Patients with Cardiovascular Disease
6 Jun 2021
Abstract excerpt
Abstract Patients with cardiovascular disease (CVD) are at increased risk of suffering myocardial infarction. Platelets are key players in thrombus formation and, therefore, antiplatelet therapy is crucial in the treatment and prevention of CVD. MicroRNAs (miRs) may hold the potential as biomarkers for platelet function and maturity. This systematic review was conducted using the guidelines of Preferred Reporting...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
